Sarah F. Adams

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Lin Zhang, Stefano Volinia, Tomás Bonome et al. · Proceedings of the National Academy of Sciences · 2008 · 520 citations · Full text

Medicine, Molecular Biology, Oncology +17

CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer

Tomoe Higuchi, Dallas B. Flies, Nicole A. Marjon et al. · Cancer Immunology Research · 2015 · 283 citations · Full text

Life Sciences, Immunology, Oncology +17

Resilience in Survivors of Critical Illness in the Context of the Survivors’ Experience and Recovery

Jason H. Maley, Isabel Brewster, Iris Mayoral et al. · Annals of the American Thoracic Society · 2016 · 167 citations · Full text

Education, Mental Health Nursing, Recovery Planning +13

Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.

S. Diane Yamada, Jonathan A. Hickson, Yancey Hrobowski et al. · PubMed · 2002 · 143 citations

Medicine, Cancer Biology, Oncology +17

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer

Angela N. Bartley, Anne M. Mills, Eric Q. Konnick et al. · Archives of Pathology & Laboratory Medicine · 2022 · 143 citations · Full text

Life Sciences, Oncology, Pathology +17